ORIC Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Updates Portfolio News / Karina Tin August 12, 2024 ORIC Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Updates Read More »
Atavistik Bio Strengthens Leadership Team with Appointment of Paul Bruno, Ph.D. as Chief Business Officer Portfolio News / Karina Tin August 12, 2024 Atavistik Bio Strengthens Leadership Team with Appointment of Paul Bruno, Ph.D. as Chief Business Officer Read More »
Tenaya Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update Portfolio News / Karina Tin August 8, 2024 Tenaya Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update Read More »
RAPT Therapeutics Reports Second Quarter 2024 Financial Results Portfolio News / Karina Tin August 8, 2024 RAPT Therapeutics Reports Second Quarter 2024 Financial Results Read More »
Tr1X Announces FDA Clearance of IND Application for TRX103, an Allogeneic Engineered Tr1 Treg Cell Therapy for Treatment-Refractory Crohn’s Disease Portfolio News / Karina Tin August 7, 2024 Tr1X Announces FDA Clearance of IND Application for TRX103, an Allogeneic Engineered Tr1 Treg Cell Therapy for Treatment-Refractory Crohn’s Disease Read More »